32nd week of 2021 patent applcation highlights part 8 |
Patent application number | Title | Published |
20210244634 | PVD-ALUMINUM PIGMENT DISPERSION AND COSMETIC FORMULATIONS | 2021-08-12 |
20210244635 | ENZYMATIC MOLECULE MIMICKING ANTI-OXIDANT ACTIVITY | 2021-08-12 |
20210244636 | COMPOSITION FOR ORAL CAVITY | 2021-08-12 |
20210244637 | DEUTERATED POLYUNSATURATED FATTY ACIDS OR ESTERS THEREOF FOR COSMETIC APPLICATIONS | 2021-08-12 |
20210244638 | INHIBITORS OF GLYCOSPHINGOLIPID SYNTHESIS AND METHODS OF USE | 2021-08-12 |
20210244639 | A COSMETIC HAIR DYEING AND/OR BLEACHING COMPOSITION, METHOD, USE AND KIT THEREOF | 2021-08-12 |
20210244640 | DETERGENT | 2021-08-12 |
20210244641 | COSMETIC | 2021-08-12 |
20210244642 | CELLULITE ERADICATION METHODS | 2021-08-12 |
20210244643 | STABLE SKIN-LIGHTENING COSMETIC COMPOSITION | 2021-08-12 |
20210244644 | TOPICAL COMPOSITION COMPRISING CROSSLINKED HYALURONIC ACID AND A POLYACRYLATE COMPOUND | 2021-08-12 |
20210244645 | ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITH | 2021-08-12 |
20210244646 | SULFATE-FREE COSMETIC RINSE-OFF COMPOSITION COMPRISING A HYPERBRANCHED COPOLYMER | 2021-08-12 |
20210244647 | METHODS AND COMPOSITIONS FOR TREATING DAMAGED HAIR | 2021-08-12 |
20210244648 | DETERGENT | 2021-08-12 |
20210244649 | COMPOSITION COMPRISING A SILICONE/POLYUREA OR SILICONE/POLYURETHANE COPOLYMER OR SILICONE/POLYUREA/POLYURETHANE COPOLYMER, A SILICONE RESIN, A VOLATILE ALKANE AND A C2-C8 MONOALCOHOL | 2021-08-12 |
20210244650 | MASK SUBSTRATE AND KIT INCLUDING THE SAME | 2021-08-12 |
20210244651 | ANTI-WRINKLE COSMETIC COMPOSITION | 2021-08-12 |
20210244652 | COSMETIC COMPOSITION FOR ANTI-AGING OR WRINKLE REDUCTION COMPRISING CULTURE BROTH OF NEURAL STEM CELLS AS ACTIVE INGREDIENT AND METHOD OF PREPARING SAME | 2021-08-12 |
20210244653 | COMBINATION OF CANNABIS, DERIVATIVES THEREOF AND ADDITIVES IN ORAL CARE COMPOSITIONS | 2021-08-12 |
20210244654 | TOPICAL SKIN FORMULATIONS | 2021-08-12 |
20210244655 | SUBLINGUAL AND BUCCAL FILM COMPOSITIONS | 2021-08-12 |
20210244656 | ISOTRETINOIN ORAL-MUCOSAL FORMULATIONS AND METHODS FOR USING SAME | 2021-08-12 |
20210244657 | EDARAVONE PHARMACEUTICAL COMPOSITION | 2021-08-12 |
20210244658 | MICRONEEDLE-ARRAY PATCHES WITH GLUCOSE-RESPONSIVE MATRIX FOR CLOSED-LOOP INSULIN DELIVERY | 2021-08-12 |
20210244659 | COMPOSITIONS AND METHODS FOR IN SITU-FORMING TISSUE CONSTRUCTS | 2021-08-12 |
20210244660 | ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS | 2021-08-12 |
20210244661 | METHOD OF TREATING EPILEPSY | 2021-08-12 |
20210244662 | INHALABLE COMPOSITIONS COMPRISING MACROCYCLIC IMMUNOSUPPRESSANTS | 2021-08-12 |
20210244663 | RAPID SET GEL CONCENTRATE FOR MEDICAL PRODUCTS | 2021-08-12 |
20210244664 | PHARMACEUTICAL COMPOSITIONS IN LYOPHILIZED FORM | 2021-08-12 |
20210244665 | NEUTRAL LIPOSOMES CONTAINING BIOLOGICALLY ACTIVE AGENTS | 2021-08-12 |
20210244666 | PIGMENT-LOADED SOLID LIPID NANOPARTICLES | 2021-08-12 |
20210244667 | HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS | 2021-08-12 |
20210244668 | Particles for Delivery of Proteins and Peptides | 2021-08-12 |
20210244669 | FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY | 2021-08-12 |
20210244670 | CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES | 2021-08-12 |
20210244671 | MONOLITHIC TABLETS BASED ON CARBOXYL POLYMERIC COMPLEXES FOR CONTROLLED DRUG RELEASE | 2021-08-12 |
20210244672 | Ingestible Product and a Method of Using the Same | 2021-08-12 |
20210244673 | BUBBLE MANUFACTURING CONTAINER | 2021-08-12 |
20210244674 | THERAPEUTIC METHOD | 2021-08-12 |
20210244675 | NANOPARTICLES WITH NON-COVALENTLY BOUND TARGETING MOIETIES FOR USE IN A THERAPEUTIC METHOD AND FOR NON-MEDICAL USE | 2021-08-12 |
20210244676 | METHODS AND COMPOSITIONS FOR MODIFYING MUCOUS MEMBRANES | 2021-08-12 |
20210244677 | ELECTROSPUN FIBERS FOR A LOCAL RELEASE OF AN ANTI-INFLAMMATORY DRUG AND A PROMYELINATING DRUG | 2021-08-12 |
20210244678 | BIOERODIBLE DRUG DELIVERY IMPLANTS | 2021-08-12 |
20210244679 | TREATMENT OF VOMITING AND NAUSEA WITH MINIMUM DOSE OF OLANZAPINE | 2021-08-12 |
20210244680 | WEARABLE LIPOSOMAL CANNABIDIOL TRANSDERMAL PATCH | 2021-08-12 |
20210244681 | TRANSTERMAL DRUG DELIVERY PATCH AND MANUFACTURING METHOD THEREOF | 2021-08-12 |
20210244682 | Method Of Treatment Or Alleviating Symptoms Of A Disorder With Cannabidiol | 2021-08-12 |
20210244683 | TOPICAL CANNABIDIOL COMPOSITION | 2021-08-12 |
20210244684 | CANNABINOID AND MENTHOL TRANSDERMAL DELIVERY SYSTEMS AND METHODS | 2021-08-12 |
20210244685 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY | 2021-08-12 |
20210244686 | Novel Systems And Methods For The Therapeutic Use of Cannabinoids or Cannabinoid Analogs to Increase The Lipid Order of Cholesterol Containing Cell Membranes | 2021-08-12 |
20210244687 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN | 2021-08-12 |
20210244688 | PHARMACEUTICAL COMPOSITION COMPRISING SALBUTAMOL | 2021-08-12 |
20210244689 | METHOD OF TREATING POSTPRANDIAL INFLAMMATION | 2021-08-12 |
20210244690 | ENANTIOMERICALLY PURE R-BETA-HYDROXYBUTYRATE MIXED SALT-ACID COMPOSITIONS | 2021-08-12 |
20210244691 | USE OF GLYCYRRHETINIC ACID, GLYCYRRHIZIC ACID AND RELATED COMPOUNDS FOR MITIGATION AND/OR TREATMENT OF PNEUMONITIS/PNEUMONIA/PULMONARY FIBROSIS INDUCED BY VIRUS INFECTION AND/OR BY CHEMICAL OR BIOLOGICAL AGENTS | 2021-08-12 |
20210244692 | METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE | 2021-08-12 |
20210244693 | NON-SURGICAL LASER TREATMENT FOR A FIBROUS MASS | 2021-08-12 |
20210244694 | BHB-Citrate Combination Products for Renal Health and Treating Disease | 2021-08-12 |
20210244695 | Methods and Compositions for Supporting Renal Health | 2021-08-12 |
20210244696 | BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS | 2021-08-12 |
20210244697 | COMPOSITIONS COMPRISING 15-OHEPA AND METHODS OF USING THE SAME | 2021-08-12 |
20210244698 | DIFFUSION ENHANCING COMPOUNDS AND THEIR USE WITH THROMBECTOMY AND EMBOLECTOMY AND OTHER VASCULAR DISEASE PROCEDURES | 2021-08-12 |
20210244699 | METHOD FOR TREATING VASO OCCLUSIVE CRISES ASSOCIATED WITH SICKLE CELL DISEASE | 2021-08-12 |
20210244700 | COMPOSITIONS AND METHODS FOR PREVENTING AND/OR REDUCING ISCHEMIA AFTER SURGICAL INCISIONS | 2021-08-12 |
20210244701 | METHOD FOR TREATING INFECTIOUS DISEASES WITH ISOTHIOCYANATE FUNCTIONAL COMPOUNDS | 2021-08-12 |
20210244702 | ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE | 2021-08-12 |
20210244703 | USE OF SCIENTIFICALLY MATCHED PLANT SUPPLEMENTS COMBINED WITH ANTINEOPLASTIC COMPOUNDS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES | 2021-08-12 |
20210244704 | Cabazitaxel in mCRPC Patients Previously Treated with Docetaxel and Who Failed a Prior androgen signaling targeted inhibitor Agent | 2021-08-12 |
20210244705 | THERAPEUTIC COMPOSITIONS, PRODUCTS OF MANUFACTURE AND METHODS FOR AMELIORATING OR PREVENTING CORONAVIRUS INFECTION | 2021-08-12 |
20210244706 | DNA Damage Repair Inhibitors for Treatment of Cancer | 2021-08-12 |
20210244707 | EXTERNAL-USE COMPOSITION | 2021-08-12 |
20210244708 | Dosage Regimen of an S1P Receptor Modulator | 2021-08-12 |
20210244709 | METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION | 2021-08-12 |
20210244710 | STABLE PHARMACEUTICAL FORMULATIONS OF OXYMETAZOLINE | 2021-08-12 |
20210244711 | CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | 2021-08-12 |
20210244712 | METHODS FOR TREATING PATIENTS WITH CANCER HAVING DEFECTS IN CYCLIN D REGULATION | 2021-08-12 |
20210244713 | ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE | 2021-08-12 |
20210244714 | PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE | 2021-08-12 |
20210244715 | GPX4 INHIBITOR IN COMBINATION WITH ANTICANCER AGENT FOR TREATING PROLIFERATIVE DISEASE | 2021-08-12 |
20210244716 | Vemurafenib and salts thereof for use in the treatment of enteroviral infections | 2021-08-12 |
20210244717 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | 2021-08-12 |
20210244718 | INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST | 2021-08-12 |
20210244719 | ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN ETEXILATE | 2021-08-12 |
20210244720 | Therapeutic Tyrosine Kinase Inhibitors for Relapsing Multiple Sclerosis (RMS) | 2021-08-12 |
20210244721 | SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF | 2021-08-12 |
20210244722 | COMPOSITIONS FOR TREATING GLAUCOMA OR REDUCING INTRAOCULAR PRESSURE | 2021-08-12 |
20210244723 | Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 | 2021-08-12 |
20210244724 | NEW THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT | 2021-08-12 |
20210244725 | USE OF MANZAMINES AS ANTIPROLIFERATIVE AGENT | 2021-08-12 |
20210244726 | THERAPEUTIC COMBINATIONS OF DRUGS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION | 2021-08-12 |
20210244727 | INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1) | 2021-08-12 |
20210244728 | Method of treating peripheral neuropathy | 2021-08-12 |
20210244729 | NOVEL CRYSTALLINE FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION | 2021-08-12 |
20210244730 | PHARMACEUTICAL COMPOSITION CONTAINING AN ANTITUMOR AGENT | 2021-08-12 |
20210244731 | TABLET CONTAINING ANTITUMOR AGENT | 2021-08-12 |
20210244732 | PACKAGING BODY OF PHARMACEUTICAL COMPOSITION CONTAINING ANTITUMOR AGENT | 2021-08-12 |
20210244733 | GRANULATED PRODUCT CONTAINING ANTITUMOR AGENT | 2021-08-12 |